Last week, the World Health Organization issued guidelines which implored women residing in countries Zika has impacted to consider delaying pregnancy, according to The Hill.
Overland, Kan.-based Health Outcomes Sciences, a provider of healthcare technology solutions, now offers personalized predictive analytics for cardiovascular patients.
The Office of the National Coordinator pinpointed six health IT complications that negatively impact patient safety and quality, according to Health IT Analytics.
The FDA approved Vantrela and Troxyca, two abuse-deterrent opioids, but also asked the medical community for better evaluations on abuse-deterrence, according to MedPage Today.
Mid-Bronx Endoscopy Center (MBEC), a new endoscopy ASC under development in the mid-Bronx, NY, has an exciting opportunity for an experienced Administrator/Director of Nursing! This position will become available late this Fall. Aside from responsibilities listed below, this person will…
New York legislation exempts drugstores from some safety and performance standards.
CMS released the results for its 2014 Ambulatory Surgical Center Quality Reporting Program, which cited the states with the highest rates and lowest rates for patient burn.
The FDA removed some paperwork physicians are required to complete to obtain experimental drugs for certain patients with immediately life-threatening illnesses, according to Kaiser Health Mews.
Boston Children's Hospital researchers have developed and tested the Global Assessment of Pediatric Patient Safety trigger tool to aid in medical adverse event tracking, according to Health Leaders Media.
The FDA's Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee have recommended the approval of Teva Pharmaceutical's VANTRELA ER, according to a Street Insider report.